These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22294128)

  • 21. Activation of 5-HT1A receptors in the rat basolateral amygdala induces both anxiolytic and antipanic-like effects.
    Strauss CV; Vicente MA; Zangrossi H
    Behav Brain Res; 2013 Jun; 246():103-10. PubMed ID: 23499701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioral characterization of the mGlu group II/III receptor antagonist, LY-341495, in animal models of anxiety and depression.
    Bespalov AY; van Gaalen MM; Sukhotina IA; Wicke K; Mezler M; Schoemaker H; Gross G
    Eur J Pharmacol; 2008 Sep; 592(1-3):96-102. PubMed ID: 18634781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testing anxiolytic drugs in the C57BL/6J mouse strain.
    Kalueff AV; Nguyen M
    J Pharmacol Toxicol Methods; 2014; 69(2):205-7. PubMed ID: 24468465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic action.
    Andreasen JT; Fitzpatrick CM; Larsen M; Skovgaard L; Nielsen SD; Clausen RP; Troelsen K; Pickering DS
    Brain Res; 2015 Mar; 1601():117-26. PubMed ID: 25578259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An assessment of anxiolytic drug screening tests: hormetic dose responses predominate.
    Calabrese EJ
    Crit Rev Toxicol; 2008; 38(6):489-542. PubMed ID: 18615308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of rat behavior in the elevated plus-maze using a directed graph.
    Tejada J; Bosco GG; Morato S; Roque AC
    J Neurosci Methods; 2009 Nov; 184(2):251-5. PubMed ID: 19699234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anxiolytic effect of neuropeptide FMRFamide in rats.
    Muthal AV; Chopde CT
    Neuropeptides; 1994 Aug; 27(2):105-8. PubMed ID: 7991064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anxiolytic-like effect of noradrenaline microinjection into the dorsal periaqueductal gray of rats.
    Pelosi GG; Resstel LL; Soares VP; Zangrossi H; Guimarães FS; Corrêa FM
    Behav Pharmacol; 2009 May; 20(3):252-9. PubMed ID: 19407657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploratory behavior models of anxiety in mice.
    Crawley JN
    Neurosci Biobehav Rev; 1985; 9(1):37-44. PubMed ID: 2858080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An approach to evaluate the ability of rats to discriminate different levels of illumination in the plus maze test: effects of scopolamine.
    de Araújo Godinho MA; Meneghini L; Lucinda AM; Borges FR; Sakae DY; Marino Neto J; Paschoalini MA; de Lima TC; Faria MS
    Behav Brain Res; 2007 Jun; 180(1):86-94. PubMed ID: 17408761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral effects of sinomenine in murine models of anxiety.
    Chen SW; Mi XJ; Wang R; Wang WJ; Kong WX; Zhang YJ; Li YL
    Life Sci; 2005 Dec; 78(3):232-8. PubMed ID: 16111714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variations in illumination, closed wall transparency and/or extramaze space influence both baseline anxiety and response to diazepam in the rat elevated plus-maze.
    Violle N; Balandras F; Le Roux Y; Desor D; Schroeder H
    Behav Brain Res; 2009 Oct; 203(1):35-42. PubMed ID: 19389429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of central administration of gonadotropin-releasing hormone agonists and antagonist on elevated plus-maze and social interaction behavior in rats.
    Umathe SN; Bhutada PS; Jain NS; Dixit PV; Wanjari MM
    Behav Pharmacol; 2008 Jul; 19(4):308-16. PubMed ID: 18622178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anxiolytic-like actions of the selective 5-HT4 receptor antagonists SB 204070A and SB 207266A in rats.
    Kennett GA; Bright F; Trail B; Blackburn TP; Sanger GJ
    Neuropharmacology; 1997; 36(4-5):707-12. PubMed ID: 9225297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relations between open-field, elevated plus-maze, and emergence tests in C57BL/6J and BALB/c mice injected with GABA- and 5HT-anxiolytic agents.
    Lalonde R; Strazielle C
    Fundam Clin Pharmacol; 2010 Jun; 24(3):365-76. PubMed ID: 19735300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats.
    Pietraszek M; Sukhanov I; Maciejak P; Szyndler J; Gravius A; Wisłowska A; Płaźnik A; Bespalov AY; Danysz W
    Eur J Pharmacol; 2005 May; 514(1):25-34. PubMed ID: 15878321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral and pharmacological validation of the elevated plus maze constructed with transparent walls.
    Anseloni VZ; Motta V; Lima G; Brandão ML
    Braz J Med Biol Res; 1995 May; 28(5):597-601. PubMed ID: 8555981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The histaminergic H1, H2, and H3 receptors of the lateral septum differentially mediate the anxiolytic-like effects of histamine on rats' defensive behaviors in the elevated plus maze and novelty-induced suppression of feeding paradigm.
    Chee SS; Menard JL
    Physiol Behav; 2013 May; 116-117():66-74. PubMed ID: 23535246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The validation of animal tests of anxiety--pharmacological implications.
    File SE
    Pol J Pharmacol Pharm; 1984; 36(5):505-12. PubMed ID: 6152493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychotropic Activity of New Fluorinated Derivatives of Tetrahydrocarbasoles.
    Nikolaeva NS; Sokolov VB; Aksinenko AY; Ovchinnikov RK; Bachurin SO; Kinzirskii AS
    Bull Exp Biol Med; 2016 Feb; 160(4):455-8. PubMed ID: 26902352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.